Catherine Clinton
Chicago, ILNPI 1346268422
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 258 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 28.4% of the total.
Across 258 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Coopersurgical, Inc.$382
- Organon$338
- Avion Pharmaceuticals$296
- Mayne Pharma Commercial LLC$240
- Pfizer$223
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,00798%
- Education$892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 75 | $1,449 |
| Coopersurgical, Inc. | 19 | $382 |
| Organon | 22 | $338 |
| Avion Pharmaceuticals | 14 | $296 |
| Mayne Pharma Commercial LLC | 12 | $240 |
| Pfizer | 8 | $223 |
| Bayer | 8 | $198 |
| Merck | 11 | $198 |
| Hologic Sales And Service, LLC | 12 | $193 |
| Agile Therapeutics, Inc. | 9 | $184 |
| Astellas Pharma US Inc | 6 | $150 |
| Exeltis, USA Inc. | 6 | $115 |
| Biogen | 5 | $107 |
| Therapeuticsmd, Inc. | 5 | $104 |
| Myovant Sciences Inc. | 4 | $100 |
| Mylan Pharmaceuticals Inc. | 4 | $85 |
| Novo Nordisk | 4 | $84 |
| AMAG Pharmaceuticals, Inc. | 4 | $75 |
| Dysis Medical, Inc. | 4 | $71 |
| Seqirus USA Inc | 3 | $62 |
| Amgen | 3 | $58 |
| Channel Medsystems, Inc. | 1 | $58 |
| Lupin Inc. | 3 | $47 |
| Duchesnay USA Incorporated | 3 | $39 |
| Mission Pharmacal Company | 3 | $37 |
| Vertical Pharmaceuticals, LLC | 2 | $36 |
| Boston Scientific | 1 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Exact Sciences | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $21 |
| Gynesonics, Inc. | 1 | $20 |
| Monaghan Medical Corporation | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Millicent US Inc | 1 | $14 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $1,215 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.